Inclusion Criteria:  advanced NSCLC (stage IIIB-IV) failure of at least one line of chemotherapy. age ≥18 years, initiation of nivolumab between 01/09/2015 and 30/09/2016.  Exclusion Criteria:  nivolumab initiation after October 2016 prior involvement in an immunotherapy trial refusal to participate.